| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/19/2013 | CN101918441B Compositions for anti-fibrinolitic treatment |
| 06/19/2013 | CN101812121B Method for efficiently extracting soil residual BT protein based on SDS buffer solution |
| 06/19/2013 | CN101798340B Plant growth coordinating and disease-resistant related gene, coded protein and application thereof |
| 06/19/2013 | CN101781642B Culture medium for identifying differential protein components in Trichoderma koningii cellulose system and application thereof |
| 06/19/2013 | CN101679504B Growth hormone fusion proteins |
| 06/19/2013 | CN101580538B WT1-origin HLA-DR-binding antigen peptide |
| 06/19/2013 | CN101432428B Recombinant human interferon-like proteins |
| 06/19/2013 | CN101353373B Synthetic peptide vaccines for foot-and-mouth disease |
| 06/19/2013 | CN101316930B T-cell adhesion molecule and antibody directed against the molecule |
| 06/19/2013 | CN101268191B Method for producing amino acids using micro-organisms |
| 06/19/2013 | CN101213204B 丙型肝炎病毒核酸疫苗 Hepatitis C virus DNA vaccine |
| 06/19/2013 | CN101146824B Means and methods for breaking noncovalent binding interactions between molecules |
| 06/19/2013 | CN101001869B Carcinoembryonic antigen fusions and uses thereof |
| 06/18/2013 | US8466352 Inbred maize variety PH18WY |
| 06/18/2013 | US8466351 Inbred maize variety PH18KJ |
| 06/18/2013 | US8466350 Tomato line FIS 14-2100 |
| 06/18/2013 | US8466344 Plant transcription factors |
| 06/18/2013 | US8466267 Nucleic acid encoding a zinc finger that recognizes the sodium channel Nav 1.8 (PN3) gene |
| 06/18/2013 | US8466258 Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis |
| 06/18/2013 | US8466172 Stabilization of hypoxia inducible factor (HIF) alpha |
| 06/18/2013 | US8466108 TFPI inhibitors and methods of use |
| 06/18/2013 | US8466106 Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof |
| 06/18/2013 | US8466105 Treatment of stroke using domain V of perlecan |
| 06/18/2013 | US8466104 Therapeutically active alpha MSH analogues |
| 06/18/2013 | US8466103 Exendin polypeptide linked to biotin, method for the preparation thereof and pharmaceutical composition comprising the same |
| 06/18/2013 | US8465981 Polypeptides, systems, and methods useful for detecting glucose |
| 06/18/2013 | US8465965 Reagents and methods for cyanobacterial production of bioplastics and biomaterials |
| 06/18/2013 | US8465948 Long-acting veterinary polypeptides and methods of producing and administering same |
| 06/18/2013 | US8465945 Method for production and use of mite group 1 proteins |
| 06/18/2013 | US8465751 Cna—B domain antigens in vaccines against gram positive bacteria |
| 06/18/2013 | US8465750 Staphylococcus aureus proteins and nucleic acids |
| 06/18/2013 | US8465747 Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapy |
| 06/18/2013 | US8465745 Chimeric antigens for eliciting an immune response |
| 06/18/2013 | US8465737 Three-dimensional structure of complement receptor type 2 and uses thereof |
| 06/18/2013 | US8465734 Methods for increasing protein polyethylene glycol (PEG) conjugation |
| 06/18/2013 | CA2650473C Protein crosslinkers, crosslinking methods and applications thereof |
| 06/18/2013 | CA2561245C Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| 06/18/2013 | CA2513701C Dimerized peptide |
| 06/18/2013 | CA2459348C Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/18/2013 | CA2446087C Recombinant tumor specific antibody and use thereof |
| 06/18/2013 | CA2440028C Rearranged squamous cell carcinoma antigen genes ii |
| 06/18/2013 | CA2439042C Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 06/18/2013 | CA2437318C Nucleotide sequence mediating male fertility and method of using same |
| 06/18/2013 | CA2418144C Urocortin proteins and uses thereof |
| 06/18/2013 | CA2415187C Dna vaccines encoding hiv accessory proteins |
| 06/18/2013 | CA2278523C Rna binding protein and binding site useful for expression of recombinant molecules |
| 06/13/2013 | WO2013086494A1 Sucrose transporters and methods of generating pathogen-resistant plants |
| 06/13/2013 | WO2013086302A1 Fractionation of proteins and lipids from microalgae |
| 06/13/2013 | WO2013085972A1 Pdgf receptor beta binding polypeptides |
| 06/13/2013 | WO2013085367A1 Cardiac troponin i-targeting peptide and use thereof |
| 06/13/2013 | WO2013083906A1 Use of at least one biomarker for the in vitro prognosis or diagnosis of lymphoproliferative episodes associated with the epstein-barr virus (ebv) |
| 06/13/2013 | WO2013083858A1 Compounds suitable for treatment of haemophilia |
| 06/13/2013 | WO2013083799A1 Mutated lentiviral env proteins and their use as drugs |
| 06/13/2013 | WO2013083781A2 Biomarkers and test panels useful in systemic inflammatory conditions |
| 06/13/2013 | WO2013083649A1 Gdf-5 mutant for inducing cartilage formation |
| 06/13/2013 | WO2013083566A1 New actinomycete integrative and conjugative element from actinoplanes sp. se50/110 as plasmid for genetic transformation of related actinobacteria |
| 06/13/2013 | WO2013083287A1 Hpv derived polynucleic acids for therapy |
| 06/13/2013 | WO2013083036A1 Porcine circovirus type-2 subunit vaccine |
| 06/13/2013 | WO2013082708A1 Cyclic peptide production |
| 06/13/2013 | WO2013057507A3 Methods for improving abiotic stress response |
| 06/13/2013 | WO2013046233A3 Process for the preparation of octreotide acetate |
| 06/13/2013 | WO2013030569A3 Cell- penetrating peptides having a central hydrophobic domain |
| 06/13/2013 | WO2013018097A3 Novel sequences for the control of reproduction in fish |
| 06/13/2013 | WO2013015589A3 Protein-protein interaction analysis method and kit using nanocluster formation |
| 06/13/2013 | WO2012175643A3 Binding domains directed against gpcr:g protein complexes and uses derived thereof |
| 06/13/2013 | US20130150565 Novel collectin |
| 06/13/2013 | US20130150564 Modified FGF-21 Polypeptides and Their Uses |
| 06/13/2013 | US20130150556 Deamidated barley proteins |
| 06/13/2013 | US20130150553 Method for protein isolation in anoxic conditions |
| 06/13/2013 | US20130150305 Method for Promoting Wound Healing |
| 06/13/2013 | US20130150303 Glycosaminoglycan-antagonising mcp-1 mutants and methods of using same |
| 06/13/2013 | US20130150302 Conjugated blood coagulation factor viii |
| 06/13/2013 | US20130150300 Specific binding sites in collagen for integrins and use thereof |
| 06/13/2013 | US20130150298 Parstatin peptides |
| 06/13/2013 | US20130150296 Albumin fusion proteins |
| 06/13/2013 | US20130150294 Na+/K+-ATPase-Specific Peptide Inhibitors/Activators of Src and Src Family Kinases |
| 06/13/2013 | US20130150288 Treatment of viral infections |
| 06/13/2013 | US20130150281 Polymeric prodrug with self-immolative linker |
| 06/13/2013 | US20130150263 Human t2r nucleic acid sequences |
| 06/13/2013 | US20130149772 Magnetic ion-exchange resin and method for the preparation thereof |
| 06/13/2013 | US20130149744 Methods for Producing a Fusion Protein Capable of Binding VEGF |
| 06/13/2013 | US20130149719 Proteins Expressed by Mycobacterium Tuberculosis and not by BCG and Their Use as Diagnostic Reagents |
| 06/13/2013 | US20130149715 G-protein-conjugated receptor having altered ligand affinity, and use thereof |
| 06/13/2013 | US20130149334 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/13/2013 | US20130149328 Plant-derived cholera and malaria vaccine |
| 06/13/2013 | US20130149327 Yersinia pestis antigens, vaccine compositions, and related methods |
| 06/13/2013 | US20130149324 Therapeutic tb vaccine |
| 06/13/2013 | US20130149309 Novel regulatory proteins and inhibitors |
| 06/13/2013 | US20130149305 Soluble cd80 as a therapeutic to reverse immune supression in cancer patients |
| 06/13/2013 | US20130149294 Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
| 06/13/2013 | US20130149289 T cell receptor mutants |
| 06/13/2013 | US20130149279 Homogeneous preparations of il-31 |
| 06/13/2013 | CA2858599A1 Cyclic peptide production |
| 06/13/2013 | CA2858519A1 Clostridium difficile toxin-based vaccine |
| 06/13/2013 | CA2858385A1 Sucrose transporters and methods of generating pathogen-resistant plants |
| 06/13/2013 | CA2858259A1 New actinomycete integrative and conjugative element from actinoplanes sp. se50/110 as plasmid for genetic transformation of related actinobacteria |
| 06/13/2013 | CA2857721A1 Pdgf receptor beta binding polypeptides |
| 06/13/2013 | CA2856458A1 Gdf-5 mutant for inducing cartilage formation |
| 06/12/2013 | EP2602264A1 GDF-5 mutant for inducing cartilage formation |
| 06/12/2013 | EP2602263A2 Polypeptides comprising an ice-binding activity |